Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05179278
Other study ID # IIBSP-CEH-2020-140
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 25, 2021
Est. completion date February 1, 2024

Study information

Verified date May 2023
Source Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this study is to evaluate the impact of a program of presurgical and postsurgical nurse interventions (PROCESS-VALVE) on quality indicators of the health of patients undergoing percutaneous valve procedures. (waiting times, patient satisfaction, admission times, hospital readmission, mortality, intrahospital complications and nosocomial infections). Design of the study is an ambispective quasi-experimental study. For the control group, data will be collected retrospectively from patients undergoing percutaneous valve procedures who did not receive pre- or postsurgical consultations. The intervention group will comprise those patients who agree to participate in the study and the haemodynamic nurse valve consultation program (PROCESS-VALVE). In addition, the investigators will assess whether a face-to-face postsurgical consultation improved quality indicators compared to postsurgical telephone consultation; for this, a sub-study will be carried out comparing face-to-face or telephone postsurgical follow-up by means of a randomised controlled clinical trial with simple blinding in the intervention group. Study area will be at the Hemodynamic Unit of the Hospital de la Santa Creu i Sant Pau and the study population are chosen patients for percutaneous valvular intervention who attend the pre-surgical consultation at our center. Dependent variable will be the indicators cited in the study aim and the independent variable will be the pre-surgical and post-surgical consultation. In pre-surgical consultation will be done a patient recruitment and will collect sociodemographic and clinical data. At patient will be done an individualized interview with an Ad-Hoc questionnaire and to collect fragility level of study and level of planned connections. In the subsequent follow-up, all pacients will receive a follow-up visit and collect satisfaction and quality indicators. But this pacients will be randomized to telephone follow-up or face-to-face follow up. Sample size has been calculated in 194 to be distributed equally in both groups and the clinical trials groups will be formed by 94 patients in each group The protocol has been modified to an ambispective quasi-experimental study with a subsequent randomization for the type of follow-up (telephone vs face-to-face) due to organizational changes in the participant center.


Recruitment information / eligibility

Status Recruiting
Enrollment 194
Est. completion date February 1, 2024
Est. primary completion date February 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients accepted for Heart-Team for percutaneous treatment aortic stenosis/insufficiency and mitral or tricuspid regurgitation - Patients visited in the pre-surgical nursing consultation Exclusion Criteria: - Patients with language barrier - Patients undergoing emergency surgery for percutaneous treatment aortic stenosis/insufficiency and mitral or tricuspid regurgitation

Study Design


Intervention

Other:
Post-surgical nurse follow-up
Follow-up face-to-face consultation or follow-up telephone consultation a month after the intervention and telephone consultation at one year

Locations

Country Name City State
Spain Hospital de la Santa Creu i Sant Pau Barcelona

Sponsors (1)

Lead Sponsor Collaborator
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Waiting time Time since Heart-team accepted until the intervention Pre-intervention
Primary Satisfaction assessed by SUCMA 14 Questionnaire Use of an adaptation Sucma 14 Questionnaire (in english Questionnaire Satisfaction of Users of Major Ambulatory Surgery). This scale is former for 14 independent questions with 5 options response (likert scale) One mounth after intervention
Primary Satisfaction assessed by SUCMA 14 Questionnaire Use of an adaptation Sucma 14 Questionnaire (in english Questionnaire Satisfaction of Users of Major Ambulatory Surgery). This scale is former for 14 independent questions with 5 options response (likert scale) One year after intervention
Primary Admission time Time since intervention until hospital discharge During hospital admission ( until the last day of admission)
Primary Rate of Hospital readmission Hospital readminission after the intervention for cardiac reasons One mounth after intervention
Primary Rate of Hospital readmission Hospital readminission after the intervention for cardiac reasons One year after intervention
Primary Rate of Mortality Mortality for all reasons (cardiac or other reason) Into admission time
Primary Rate of Mortality Mortality for all reasons (cardiac or other reason) One mounth after intervention
Primary Rate of Mortality Mortality for all reasons (cardiac or other reason) One year after intervention
Primary Rate of Intrahospital complications Procedure complications (vascular, stroke and cardiac complication) Into admission time
Primary Rate of Intrahospital complications Procedure complications (vascular, stroke and cardiac complication) One mounth after intervention
Primary Rate of Intrahospital complications Procedure complications (vascular, stroke and cardiac complication) One year after intervention
Primary Rate of Nosocomial infection Infection adquired during hospital admission During hospital admission (until the last day of admission)
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Completed NCT02241109 - Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity N/A
Completed NCT03799133 - Safety and Efficacy of the Gastric Reactance (XL) in Patients Post-operated of Elective Cardiac Surgery N/A
Completed NCT01676727 - ADVANCE Direct Aortic Study
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A
Completed NCT00721136 - Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation N/A
Recruiting NCT05044338 - Study on Standard Evaluation System and Optimal Treatment Path of Senile Valvular Heart Disease
Recruiting NCT05014750 - Frailty of Elderly With Valvular Heart Disease and the Short Term Adverse Events
Recruiting NCT05015829 - Diagnostic Impact of Low-dose Dobutamine Echocardiography in Low-flow Low-gradient Aortic Stenosis
Recruiting NCT05078619 - Percutaneous Coronary Intervention Before Transcatheter Aortic Valve Implantation N/A
Recruiting NCT06307262 - European Registry of Transcatheter Repair for Tricuspid Regurgitation
Completed NCT01624870 - CoreValve Advance-II Study: Prospective International Post-market Study
Recruiting NCT06077201 - Home-Based Cardiac Rehabilitation Using a Novel Mobile Health Exercise Regimen Following Transcatheter Heart Valve Interventions N/A
Completed NCT05708690 - Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery Phase 4
Recruiting NCT03797820 - Multicenter Registry Study of Aortic Valve Stenosis in Zhejiang Elderly(Mrs AVS)
Recruiting NCT06077721 - Milrinone on Right Ventricular Strain in Cardiac Surgery
Not yet recruiting NCT04632914 - Effect of Trunk Stabilizing Exercises on Patients With Median Sternotomy After Heart Valve Surgery N/A
Completed NCT01477151 - Randomized Isoflurane and Sevoflurane Comparison in Cardiac Surgery Phase 4
Terminated NCT03590730 - Benefits of ICD for the Primary Prevention in Patients With Valvular Cardiomyopathy
Recruiting NCT06204783 - Real-time Pressure Volume Loop Monitoring as a Guide for Enhanced Understanding of Changes in Elemental Cardiovascular Physiology During Therapeutic Strategies Aiming for Hemodynamic Optimization. Cohort II: Structural Heart Interventions (PLUTO-II)